🇺🇸 LGND — Ligand Pharmaceuticals Incorporated
Salud Compra fuertePrecio actual
306,20 USD
Máx. histórico
322,75
7 días
Split 1603:1000 del 02/11/2022
Caída desde máximo
-5,13%
Rango 52 semanas
175,89 – 326,63
Variación hoy
+2,41%
Cierre anterior
299,00
Rango de hoy
297,84 – 308,26
Volumen hoy
130.173
Peor caída histórica
-93,34%
06/03/2000 → 19/11/2008
Recuperado en 2694 días
Volatilidad anualizada ⓘ
59,76%
- Nombre completo
- Ligand Pharmaceuticals Incorporated
- Divisa
- USD
- Mercado
- NasdaqGM
- Sector
- Salud
- Industria
- Biotechnology
- Empleados
- 47
- PER ⓘ
- 122,97 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 351,33 USD (puede no estar actualizado)
- Primera cotización
- 18/11/1992
- Precio actualizado
- hace 23 horas
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, develops and licenses biopharmaceutical assets worldwide. It offers Pradefovir, Posaconazole, Voriconazole, CAPVAXIVE, NOXAFIL, MenFive, and ZELSUVMI for infectious disease; EVOMELA and KYPROLIS for multiple myeloma; FILSPARI for the treatment of immunoglobulin a nephropathy; PNEUMOSIL, a pneumococcal conjugate vaccine to help fight against pneumococcal pneumonia in children; and QARZIBA to treat neuroblastoma. The company also provides Teriparatide injection product for osteoporosis; RYLAZE, a recombinant erwinia asparaginase for acute lymphoblastic leukemia or lymphoblastic lymphoma in adult and pediatric patients; TZIELD, a CD3-directed antibody indicated to delay the onset of Stage 3 type 1 diabetes in adults and children aged 8 years and older with Stage 2 T1D; and VAXNEUVANCE for the prevention of invasive disease caused by streptococcus pneumoniae serotypes. In addition, it offers Duavee for menopause; Frovatriptan to treat Neurology; FYCOMPA and SESQUIENT for CNS; MEKINIST for cardiology; Nexterone, a captisol-enabled formulation of amiodarone; VEKLURY, an antiviral treatment for COVID-19; and Viviant for osteoporosis. Further, the company develops ACLX-002, Ciforadenant, UGN-301, Viright, MB07133, BOT/BAL, and Lasofoxifene for oncology; Ensifentrine for respiratory disease; QTORIN for rare disease; Sparsentan for kidney disease; VK2809 for hepatology; ANEB-001 for acute cannabinoid intoxication; Reproxalap for opthamology; VK0214 for Rare Disease; and VK5211 for musculoskeletal disorder. The company was incorporated in 1987 and is based in Jupiter, Florida.
| Fecha de pago | Importe por participación |
|---|---|
| 03/04/2007 | 9,3575 USD |
| Fecha | Ratio |
|---|---|
| 02/11/2022 | 1603:1000 |
| 19/11/2010 | 1:6 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 02/04/2008 | 15,38 | 15,50 | 14,90 | 15,42 | -0,48% | 3,89% | 146.862 |
| 01/04/2008 | 15,23 | 15,53 | 15,01 | 15,50 | +3,50% | 3,44% | 131.713 |
| 31/03/2008 | 14,52 | 15,35 | 14,30 | 14,97 | +3,09% | 7,22% | 112.851 |
| 28/03/2008 | 15,01 | 15,42 | 14,34 | 14,52 | -3,00% | 7,23% | 104.382 |
| 27/03/2008 | 15,31 | 15,53 | 14,67 | 14,97 | -0,99% | 5,62% | 124.152 |
| 26/03/2008 | 15,08 | 15,65 | 14,90 | 15,12 | -1,22% | 4,96% | 116.351 |
| 25/03/2008 | 15,80 | 15,91 | 14,93 | 15,31 | -2,85% | 6,16% | 127.465 |
| 24/03/2008 | 14,60 | 15,83 | 14,45 | 15,76 | +8,51% | 9,49% | 225.569 |
| 20/03/2008 | 14,97 | 14,97 | 13,89 | 14,52 | -0,77% | 7,25% | 558.405 |
| 19/03/2008 | 14,97 | 15,23 | 14,04 | 14,64 | -2,00% | 8,00% | 180.818 |
| 18/03/2008 | 14,15 | 14,93 | 13,06 | 14,93 | +8,72% | 13,23% | 225.515 |
| 17/03/2008 | 14,64 | 15,08 | 13,47 | 13,74 | -6,85% | 11,00% | 165.483 |
| 14/03/2008 | 15,01 | 15,27 | 13,81 | 14,75 | -1,50% | 9,73% | 185.708 |
| 13/03/2008 | 14,19 | 15,12 | 13,66 | 14,97 | +4,44% | 10,29% | 191.799 |
| 12/03/2008 | 14,67 | 14,97 | 14,11 | 14,34 | -1,54% | 5,87% | 100.615 |
| 11/03/2008 | 13,70 | 14,56 | 12,91 | 14,56 | +10,20% | 12,02% | 164.922 |
| 10/03/2008 | 14,15 | 14,30 | 12,73 | 13,21 | -6,12% | 11,11% | 257.495 |
| 07/03/2008 | 13,40 | 14,07 | 13,14 | 14,07 | +4,15% | 6,98% | 221.241 |
| 06/03/2008 | 13,51 | 14,00 | 13,29 | 13,51 | -0,82% | 5,26% | 197.089 |
| 05/03/2008 | 14,04 | 14,15 | 13,29 | 13,62 | -1,89% | 6,13% | 156.693 |
| 04/03/2008 | 13,70 | 14,07 | 13,25 | 13,89 | +0,82% | 6,01% | 162.998 |
| 03/03/2008 | 13,33 | 14,75 | 13,33 | 13,77 | +8,55% | 10,67% | 217.153 |
| 29/02/2008 | 13,25 | 13,44 | 12,58 | 12,69 | -5,57% | 6,50% | 186.963 |
| 28/02/2008 | 13,81 | 14,30 | 13,33 | 13,44 | -4,52% | 7,05% | 156.960 |
| 27/02/2008 | 14,71 | 14,90 | 13,74 | 14,07 | -5,53% | 7,89% | 153.514 |
| 26/02/2008 | 12,95 | 15,53 | 12,91 | 14,90 | +14,04% | 20,23% | 255.625 |
| 25/02/2008 | 13,10 | 13,40 | 12,76 | 13,06 | -0,29% | 4,86% | 91.318 |
| 22/02/2008 | 13,14 | 13,18 | 12,61 | 13,10 | -0,29% | 4,27% | 174.834 |
| 21/02/2008 | 14,75 | 15,12 | 12,39 | 13,14 | -12,47% | 18,53% | 269.705 |
| 20/02/2008 | 14,90 | 15,27 | 13,85 | 15,01 | +0,25% | 9,55% | 185.200 |